4D Molecular Therapeutics FDMT
NASDAQ FDMT
$14.49 -0.07 (-0.48%)
At close: Sep 29, 2026 · 4:00 PM EDT

4D Molecular Therapeutics (FDMT) Receivables (2019 - 2021)

Updated

4D Molecular Therapeutics (FDMT) posted Receivables of $47,000 for Q4 2021, down 96.8% from $1.49 million a year earlier and down 94.1% from the prior quarter.

Analysis

4D Molecular Therapeutics (FDMT) Receivables (2019 - 2021) Analysis & Trends

Since Q4 2019, 4D Molecular Therapeutics has reported Receivables for 6 quarters.

  • In prior years, 4D Molecular Therapeutics' Receivables was $1.66 million in FY2020 (+46.9%) and $1.13 million in FY2019.
  • According to Business Quant data, Receivables for the three prior quarters was $800,000 (Q3 2021), $1.22 million (Q2 2021) and $1.56 million (Q1 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 19.05 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 13.82 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.56 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 9.64 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 15.68 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 10.23 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 5.06 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 12.49 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.13 Bn
10 4D Molecular Therapeutics 1.02 Bn -436.78 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 47,000.00
Sep 30, 2021 800,000.00
Jun 30, 2021 1.22 Mn
Mar 31, 2021 1.56 Mn
Dec 31, 2020 1.49 Mn
Dec 31, 2019 978,000.00
API Access

4D Molecular Therapeutics Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=FDMT&period=max&api_key=YOUR_API_KEY